Construction And Real Estate Tenders

Medicines with the Active Ingredient Secukinumab (Atc: L04ac10)

Medicines with the Active Ingredient Mesalazine (Atc: A07ec02)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Aripiprazole as a Depot Injection Suspension (Atc Code: N05ax12).

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Glatiramer Acetate (Atc Code According to Who: L03ax13)

Medicines with the Active Ingredient Leuprorelin (Atc: L02ae02)

Medicines with the Active Ingredient Pegfilgrastim (Atc: L03aa13)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Guselkumab

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Medicines with the Active Ingredient Epinephrine (Atc: C01ca24)

Conclusion of a Non-Exclusive Supplementary Agreement in Accordance with Section 135A Sgb V to Improve Quality and Transparency Within the Framework of a So-Called "Open House Model"